FINWIRES · TerminalLIVE
FINWIRES

Bernstein Adjusts Price Target on Biogen to $200 From $201

By

Biogen (BIIB) has an average rating of overweight and mean price target of $215.86, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $191.77, Change: $-2.61, Percent Change: -1.34%

Related Articles